green valley pharmaceutical
Promising Phase 3 Results For Green Valley’s Alzheimer’s Drug
The marine-derived compound GV-971 was found to be safe and effective for treating mild-to-moderate Alzheimer’s disease.
The marine-derived compound GV-971 was found to be safe and effective for treating mild-to-moderate Alzheimer’s disease.
